Rochester, NY 8/27/2009 4:07:05 PM
Acura Pharmaceuticals Inc. ACUR, Acura Pharmaceuticals finished the day at 0.51%
Acura Pharmaceuticals Inc. ACUR
Acura Pharmaceuticals recently release its last trading $5.97 or 0.5 percent at closed market. During the day stock range from $5.90 - $6.25. The company average volume was hit of 57,122.7 after the market closed.
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of Aversion Technology related product candidates. The company’s Aversion Technology acts as a platform for developing multiple opioid analgesic products candidates containing codeine, propoxyphene, morphine, hydrocodone, oxycodone, tramadol, and various other opioid analgesics.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to BOTTOM of this page for free stock alerts, or visit our site.
Last Trade: 5.97
Day's Range: 5.90 - 6.25
52wk Range: 3.43 - 9.00
Change: 0.00 (0.00%)
Volume: 0
Avg Vol (3m): 57,122.7
ABOUT Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of Aversion Technology related product candidates. The company's Aversion Technology acts as a platform for developing multiple opioid analgesic products candidates containing codeine, propoxyphene, morphine, hydrocodone, oxycodone, tramadol, and various other opioid analgesics. Its opioid analgesic products are used to relieve pain, as well as to discourage common methods of pharmaceutical product misuse and abuse, including intravenous injection of dissolved tablets or capsules; nasal snorting of crushed tablets or capsules; and intentional swallowing of excess quantities of tablets or capsules. The company has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc. to develop and commercialize opioid analgesic products, including Acurox tablets, an orally administered immediate release tablet containing oxycodone HCl; Acuracet tablets containing oxycodone HCl/niacin/APAP; and Vycavert tablets containing hydrocodone bitartrate/niacin/APAP utilizing the Aversion Technology in the United States, Canada, and Mexico. Acura Pharmaceuticals, Inc. was founded in 1935 and is based in Palatine, Illinois.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
